KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 11.7% to $2.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 billion, a 11.7% increase, with the full-year FY2025 number at $2.9 billion, up 11.7% from a year prior.
  • Total Non-Current Liabilities was $2.9 billion for Q4 2025 at Bio-Rad Laboratories, up from $2.8 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $4.4 billion in Q3 2021 to a low of $2.6 billion in Q4 2024.
  • A 5-year average of $3.3 billion and a median of $3.3 billion in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: surged 46.22% in 2021, then fell 22.85% in 2022.
  • Bio-Rad Laboratories' Total Non-Current Liabilities stood at $3.9 billion in 2021, then dropped by 6.01% to $3.7 billion in 2022, then decreased by 8.88% to $3.4 billion in 2023, then decreased by 22.16% to $2.6 billion in 2024, then grew by 11.7% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BIO's Total Non-Current Liabilities are $2.9 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.9 billion (Q2 2025).